Illumine Investment Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$946K Buy
10,163
+46
+0.5% +$4.07K 0.73% 52
2025
Q4
$813K Buy
10,117
+86
+0.9% +$7.2K 0.59% 56
2025
Q3
$979K Buy
10,031
+93
+0.9% +$7.49K 0.7% 52
2025
Q2
$693K Buy
9,938
+207
+2% +$11.8K 0.55% 60
2025
Q1
$483K Buy
+9,731
New +$615K 0.4% 75

Other funds holding ACLS

Illumine Investment Management's ACLS Position: Q1 2026 in Review

Illumine Investment Management increased its Axcelis (ACLS) stake by 0.45% in Q1 2026, buying an estimated $4.07K and bringing the position to 10,163 shares worth $946K. The position accounts for 0.73% of the portfolio, ranked #52.

Illumine Investment Management first reported a position in ACLS in Q1 2025 and has held it in 5 quarters since. The position peaked at $979K in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Illumine Investment Management held 10,163 shares of Axcelis worth $946K as of Q1 2026.
  • Illumine Investment Management bought 46 Axcelis shares in Q1 2026, an estimated $4.07K.
  • Axcelis made up 0.73% of Illumine Investment Management's portfolio in Q1 2026, its #52 holding.
  • Illumine Investment Management first reported a position in Axcelis in Q1 2025 and has held it in 5 quarters since.
  • Illumine Investment Management's Axcelis position peaked at $979K in Q3 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Illumine Investment Management's 13F filing for Q1 2026, filed 4 May 2026.